nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—CACNA1S—pes—melanoma	0.0717	0.385	CbGeAlD
Nimodipine—CYP3A4—Temozolomide—melanoma	0.0577	0.451	CbGbCtD
Nimodipine—CYP3A4—Vemurafenib—melanoma	0.0316	0.247	CbGbCtD
Nimodipine—CYP3A5—Docetaxel—melanoma	0.0278	0.217	CbGbCtD
Nimodipine—CACNA1D—ear—melanoma	0.0165	0.0888	CbGeAlD
Nimodipine—CACNA1F—eye—melanoma	0.0147	0.079	CbGeAlD
Nimodipine—CACNA1F—retina—melanoma	0.0146	0.0783	CbGeAlD
Nimodipine—CYP3A4—Docetaxel—melanoma	0.0108	0.0848	CbGbCtD
Nimodipine—Vasospasm—Carmustine—melanoma	0.00999	0.046	CcSEcCtD
Nimodipine—CACNA1F—head—melanoma	0.00835	0.0448	CbGeAlD
Nimodipine—Disseminated intravascular coagulation—Docetaxel—melanoma	0.00614	0.0283	CcSEcCtD
Nimodipine—CACNB3—mammalian vulva—melanoma	0.00588	0.0316	CbGeAlD
Nimodipine—CACNB4—head—melanoma	0.00549	0.0295	CbGeAlD
Nimodipine—Deep vein thrombosis—Temozolomide—melanoma	0.00542	0.025	CcSEcCtD
Nimodipine—CACNB2—retina—melanoma	0.00494	0.0265	CbGeAlD
Nimodipine—CACNB1—head—melanoma	0.00439	0.0236	CbGeAlD
Nimodipine—AHR—mammalian vulva—melanoma	0.00436	0.0234	CbGeAlD
Nimodipine—CACNB3—head—melanoma	0.00421	0.0226	CbGeAlD
Nimodipine—Wheezing—Bleomycin—melanoma	0.0038	0.0175	CcSEcCtD
Nimodipine—NR3C2—retina—melanoma	0.00363	0.0195	CbGeAlD
Nimodipine—Deep vein thrombosis—Docetaxel—melanoma	0.00361	0.0166	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Temozolomide—melanoma	0.0033	0.0152	CcSEcCtD
Nimodipine—Phlebitis—Bleomycin—melanoma	0.00329	0.0152	CcSEcCtD
Nimodipine—Ileus—Docetaxel—melanoma	0.0031	0.0143	CcSEcCtD
Nimodipine—CACNB1—lymph node—melanoma	0.00307	0.0165	CbGeAlD
Nimodipine—Phlebitis—Dactinomycin—melanoma	0.00307	0.0141	CcSEcCtD
Nimodipine—Cardiac disorder—Vemurafenib—melanoma	0.00301	0.0138	CcSEcCtD
Nimodipine—CACNB3—lymph node—melanoma	0.00295	0.0158	CbGeAlD
Nimodipine—Angiopathy—Vemurafenib—melanoma	0.00294	0.0135	CcSEcCtD
Nimodipine—NR3C2—mammalian vulva—melanoma	0.0029	0.0156	CbGeAlD
Nimodipine—Phlebitis—Carmustine—melanoma	0.00288	0.0132	CcSEcCtD
Nimodipine—CACNB2—head—melanoma	0.00283	0.0152	CbGeAlD
Nimodipine—Blood alkaline phosphatase increased—Temozolomide—melanoma	0.00275	0.0127	CcSEcCtD
Nimodipine—Hyponatraemia—Carmustine—melanoma	0.00249	0.0114	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Carmustine—melanoma	0.00248	0.0114	CcSEcCtD
Nimodipine—CACNA1D—head—melanoma	0.00247	0.0133	CbGeAlD
Nimodipine—Liver function test abnormal—Dactinomycin—melanoma	0.00244	0.0112	CcSEcCtD
Nimodipine—Myalgia—Vemurafenib—melanoma	0.0024	0.0111	CcSEcCtD
Nimodipine—Liver function test abnormal—Carmustine—melanoma	0.00229	0.0105	CcSEcCtD
Nimodipine—CACNA1C—head—melanoma	0.00228	0.0122	CbGeAlD
Nimodipine—Nervous system disorder—Vemurafenib—melanoma	0.00226	0.0104	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Docetaxel—melanoma	0.00219	0.0101	CcSEcCtD
Nimodipine—AHR—lymph node—melanoma	0.00218	0.0117	CbGeAlD
Nimodipine—Hypotension—Vemurafenib—melanoma	0.00215	0.0099	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Temozolomide—melanoma	0.00211	0.00972	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.0021	0.00966	CcSEcCtD
Nimodipine—Fluid retention—Docetaxel—melanoma	0.00208	0.00958	CcSEcCtD
Nimodipine—NR3C2—head—melanoma	0.00208	0.0111	CbGeAlD
Nimodipine—Sweating increased—Temozolomide—melanoma	0.00202	0.00928	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Vemurafenib—melanoma	0.00199	0.00915	CcSEcCtD
Nimodipine—CACNB2—lymph node—melanoma	0.00198	0.0106	CbGeAlD
Nimodipine—Lightheadedness—Docetaxel—melanoma	0.00196	0.00903	CcSEcCtD
Nimodipine—Depression—Carmustine—melanoma	0.0019	0.00876	CcSEcCtD
Nimodipine—Phlebitis—Docetaxel—melanoma	0.00185	0.00851	CcSEcCtD
Nimodipine—Depression—Temozolomide—melanoma	0.00184	0.00847	CcSEcCtD
Nimodipine—Hepatitis—Dactinomycin—melanoma	0.00183	0.00843	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.00183	0.00843	CcSEcCtD
Nimodipine—Flushing—Bleomycin—melanoma	0.00182	0.00839	CcSEcCtD
Nimodipine—Cardiac failure congestive—Docetaxel—melanoma	0.00176	0.00808	CcSEcCtD
Nimodipine—Hepatobiliary disease—Temozolomide—melanoma	0.00174	0.00803	CcSEcCtD
Nimodipine—CACNA1D—lymph node—melanoma	0.00173	0.00929	CbGeAlD
Nimodipine—Flushing—Dactinomycin—melanoma	0.0017	0.00782	CcSEcCtD
Nimodipine—Hypersensitivity—Vemurafenib—melanoma	0.0017	0.00781	CcSEcCtD
Nimodipine—Hepatitis—Temozolomide—melanoma	0.00166	0.00762	CcSEcCtD
Nimodipine—Pruritus—Vemurafenib—melanoma	0.00163	0.0075	CcSEcCtD
Nimodipine—Hyponatraemia—Docetaxel—melanoma	0.0016	0.00736	CcSEcCtD
Nimodipine—CACNA1C—lymph node—melanoma	0.0016	0.00858	CbGeAlD
Nimodipine—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.00159	0.00733	CcSEcCtD
Nimodipine—Flushing—Carmustine—melanoma	0.00159	0.00732	CcSEcCtD
Nimodipine—Anaemia—Bleomycin—melanoma	0.00158	0.00727	CcSEcCtD
Nimodipine—Diarrhoea—Vemurafenib—melanoma	0.00158	0.00725	CcSEcCtD
Nimodipine—Cardiac disorder—Temozolomide—melanoma	0.00154	0.00708	CcSEcCtD
Nimodipine—Flushing—Temozolomide—melanoma	0.00154	0.00708	CcSEcCtD
Nimodipine—Dizziness—Vemurafenib—melanoma	0.00152	0.00701	CcSEcCtD
Nimodipine—Angiopathy—Temozolomide—melanoma	0.0015	0.00692	CcSEcCtD
Nimodipine—Immune system disorder—Temozolomide—melanoma	0.0015	0.00689	CcSEcCtD
Nimodipine—Anaemia—Dactinomycin—melanoma	0.00147	0.00678	CcSEcCtD
Nimodipine—Liver function test abnormal—Docetaxel—melanoma	0.00147	0.00677	CcSEcCtD
Nimodipine—Vomiting—Vemurafenib—melanoma	0.00146	0.00674	CcSEcCtD
Nimodipine—Myalgia—Bleomycin—melanoma	0.00146	0.0067	CcSEcCtD
Nimodipine—NR3C2—lymph node—melanoma	0.00145	0.00781	CbGeAlD
Nimodipine—Rash—Vemurafenib—melanoma	0.00145	0.00668	CcSEcCtD
Nimodipine—Dermatitis—Vemurafenib—melanoma	0.00145	0.00668	CcSEcCtD
Nimodipine—Headache—Vemurafenib—melanoma	0.00144	0.00664	CcSEcCtD
Nimodipine—Cramp muscle—Docetaxel—melanoma	0.00143	0.0066	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Docetaxel—melanoma	0.0014	0.00646	CcSEcCtD
Nimodipine—Oedema—Bleomycin—melanoma	0.00139	0.00642	CcSEcCtD
Nimodipine—Anaemia—Carmustine—melanoma	0.00138	0.00635	CcSEcCtD
Nimodipine—Nausea—Vemurafenib—melanoma	0.00137	0.0063	CcSEcCtD
Nimodipine—Thrombocytopenia—Bleomycin—melanoma	0.00137	0.00629	CcSEcCtD
Nimodipine—Myalgia—Dactinomycin—melanoma	0.00136	0.00625	CcSEcCtD
Nimodipine—Anaemia—Temozolomide—melanoma	0.00133	0.00613	CcSEcCtD
Nimodipine—Hypotension—Bleomycin—melanoma	0.0013	0.006	CcSEcCtD
Nimodipine—Oedema—Dactinomycin—melanoma	0.0013	0.00599	CcSEcCtD
Nimodipine—Hypertension—Carmustine—melanoma	0.00129	0.00593	CcSEcCtD
Nimodipine—Palpitations—Temozolomide—melanoma	0.00127	0.00586	CcSEcCtD
Nimodipine—Thrombocytopenia—Dactinomycin—melanoma	0.00127	0.00586	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Bleomycin—melanoma	0.00127	0.00585	CcSEcCtD
Nimodipine—Myalgia—Carmustine—melanoma	0.00127	0.00585	CcSEcCtD
Nimodipine—Hypertension—Temozolomide—melanoma	0.00124	0.00573	CcSEcCtD
Nimodipine—Dyspnoea—Bleomycin—melanoma	0.00124	0.00572	CcSEcCtD
Nimodipine—Myalgia—Temozolomide—melanoma	0.00123	0.00565	CcSEcCtD
Nimodipine—Oedema—Carmustine—melanoma	0.00122	0.0056	CcSEcCtD
Nimodipine—Jaundice—Docetaxel—melanoma	0.0012	0.0055	CcSEcCtD
Nimodipine—Thrombocytopenia—Carmustine—melanoma	0.00119	0.00549	CcSEcCtD
Nimodipine—Tachycardia—Carmustine—melanoma	0.00119	0.00547	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00119	0.00546	CcSEcCtD
Nimodipine—Oedema—Temozolomide—melanoma	0.00118	0.00542	CcSEcCtD
Nimodipine—Hepatobiliary disease—Docetaxel—melanoma	0.00116	0.00534	CcSEcCtD
Nimodipine—Nervous system disorder—Temozolomide—melanoma	0.00115	0.00531	CcSEcCtD
Nimodipine—Thrombocytopenia—Temozolomide—melanoma	0.00115	0.0053	CcSEcCtD
Nimodipine—Hypotension—Carmustine—melanoma	0.00114	0.00524	CcSEcCtD
Nimodipine—Hyperhidrosis—Temozolomide—melanoma	0.00114	0.00524	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Carmustine—melanoma	0.00111	0.00511	CcSEcCtD
Nimodipine—Hepatitis—Docetaxel—melanoma	0.0011	0.00507	CcSEcCtD
Nimodipine—Dyspnoea—Carmustine—melanoma	0.00109	0.005	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Temozolomide—melanoma	0.00107	0.00493	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Carmustine—melanoma	0.00105	0.00484	CcSEcCtD
Nimodipine—Dyspnoea—Temozolomide—melanoma	0.00105	0.00483	CcSEcCtD
Nimodipine—Hypersensitivity—Bleomycin—melanoma	0.00103	0.00473	CcSEcCtD
Nimodipine—Flushing—Docetaxel—melanoma	0.00102	0.00471	CcSEcCtD
Nimodipine—Cardiac disorder—Docetaxel—melanoma	0.00102	0.00471	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Temozolomide—melanoma	0.00102	0.00468	CcSEcCtD
Nimodipine—Angiopathy—Docetaxel—melanoma	0.000999	0.0046	CcSEcCtD
Nimodipine—Immune system disorder—Docetaxel—melanoma	0.000995	0.00458	CcSEcCtD
Nimodipine—Pruritus—Bleomycin—melanoma	0.000987	0.00454	CcSEcCtD
Nimodipine—Hypersensitivity—Dactinomycin—melanoma	0.000958	0.00441	CcSEcCtD
Nimodipine—Muscle spasms—Docetaxel—melanoma	0.000922	0.00424	CcSEcCtD
Nimodipine—Hypersensitivity—Carmustine—melanoma	0.000897	0.00413	CcSEcCtD
Nimodipine—Diarrhoea—Dactinomycin—melanoma	0.00089	0.0041	CcSEcCtD
Nimodipine—Vomiting—Bleomycin—melanoma	0.000887	0.00408	CcSEcCtD
Nimodipine—Anaemia—Docetaxel—melanoma	0.000886	0.00408	CcSEcCtD
Nimodipine—Rash—Bleomycin—melanoma	0.000879	0.00405	CcSEcCtD
Nimodipine—Dermatitis—Bleomycin—melanoma	0.000879	0.00404	CcSEcCtD
Nimodipine—Hypersensitivity—Temozolomide—melanoma	0.000867	0.00399	CcSEcCtD
Nimodipine—Palpitations—Docetaxel—melanoma	0.000847	0.0039	CcSEcCtD
Nimodipine—Diarrhoea—Carmustine—melanoma	0.000833	0.00383	CcSEcCtD
Nimodipine—Pruritus—Temozolomide—melanoma	0.000832	0.00383	CcSEcCtD
Nimodipine—Nausea—Bleomycin—melanoma	0.000829	0.00381	CcSEcCtD
Nimodipine—Hypertension—Docetaxel—melanoma	0.000828	0.00381	CcSEcCtD
Nimodipine—Vomiting—Dactinomycin—melanoma	0.000827	0.00381	CcSEcCtD
Nimodipine—Rash—Dactinomycin—melanoma	0.00082	0.00378	CcSEcCtD
Nimodipine—Myalgia—Docetaxel—melanoma	0.000816	0.00376	CcSEcCtD
Nimodipine—Dizziness—Carmustine—melanoma	0.000805	0.00371	CcSEcCtD
Nimodipine—Diarrhoea—Temozolomide—melanoma	0.000805	0.00371	CcSEcCtD
Nimodipine—Oedema—Docetaxel—melanoma	0.000782	0.0036	CcSEcCtD
Nimodipine—Dizziness—Temozolomide—melanoma	0.000778	0.00358	CcSEcCtD
Nimodipine—Vomiting—Carmustine—melanoma	0.000774	0.00356	CcSEcCtD
Nimodipine—Nausea—Dactinomycin—melanoma	0.000773	0.00356	CcSEcCtD
Nimodipine—Rash—Carmustine—melanoma	0.000768	0.00353	CcSEcCtD
Nimodipine—Nervous system disorder—Docetaxel—melanoma	0.000767	0.00353	CcSEcCtD
Nimodipine—Dermatitis—Carmustine—melanoma	0.000767	0.00353	CcSEcCtD
Nimodipine—Thrombocytopenia—Docetaxel—melanoma	0.000766	0.00353	CcSEcCtD
Nimodipine—Tachycardia—Docetaxel—melanoma	0.000764	0.00352	CcSEcCtD
Nimodipine—Headache—Carmustine—melanoma	0.000763	0.00351	CcSEcCtD
Nimodipine—Vomiting—Temozolomide—melanoma	0.000748	0.00344	CcSEcCtD
Nimodipine—Rash—Temozolomide—melanoma	0.000742	0.00342	CcSEcCtD
Nimodipine—Dermatitis—Temozolomide—melanoma	0.000741	0.00341	CcSEcCtD
Nimodipine—Headache—Temozolomide—melanoma	0.000737	0.00339	CcSEcCtD
Nimodipine—Hypotension—Docetaxel—melanoma	0.000731	0.00337	CcSEcCtD
Nimodipine—Nausea—Carmustine—melanoma	0.000723	0.00333	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000713	0.00328	CcSEcCtD
Nimodipine—Nausea—Temozolomide—melanoma	0.000699	0.00322	CcSEcCtD
Nimodipine—Dyspnoea—Docetaxel—melanoma	0.000698	0.00321	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Docetaxel—melanoma	0.000676	0.00311	CcSEcCtD
Nimodipine—Hypersensitivity—Docetaxel—melanoma	0.000576	0.00265	CcSEcCtD
Nimodipine—Pruritus—Docetaxel—melanoma	0.000554	0.00255	CcSEcCtD
Nimodipine—Diarrhoea—Docetaxel—melanoma	0.000535	0.00246	CcSEcCtD
Nimodipine—Dizziness—Docetaxel—melanoma	0.000517	0.00238	CcSEcCtD
Nimodipine—Vomiting—Docetaxel—melanoma	0.000498	0.00229	CcSEcCtD
Nimodipine—Rash—Docetaxel—melanoma	0.000493	0.00227	CcSEcCtD
Nimodipine—Dermatitis—Docetaxel—melanoma	0.000493	0.00227	CcSEcCtD
Nimodipine—Headache—Docetaxel—melanoma	0.00049	0.00226	CcSEcCtD
Nimodipine—Nausea—Docetaxel—melanoma	0.000465	0.00214	CcSEcCtD
Nimodipine—Nisoldipine—ABCB1—melanoma	0.000282	0.203	CrCbGaD
Nimodipine—Nitrendipine—ABCB1—melanoma	0.000263	0.19	CrCbGaD
Nimodipine—Amlodipine—ABCB1—melanoma	0.000227	0.164	CrCbGaD
Nimodipine—Felodipine—ABCB1—melanoma	0.00021	0.151	CrCbGaD
Nimodipine—Nifedipine—ABCB1—melanoma	0.000203	0.147	CrCbGaD
Nimodipine—Nicardipine—ABCB1—melanoma	0.0002	0.144	CrCbGaD
Nimodipine—CACNB3—Developmental Biology—KRAS—melanoma	9.12e-05	0.000195	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PRKCA—melanoma	9.1e-05	0.000195	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—KRAS—melanoma	9.1e-05	0.000195	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—NRAS—melanoma	9.07e-05	0.000194	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ERCC2—melanoma	9.03e-05	0.000193	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HS3ST5—melanoma	8.96e-05	0.000192	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TNF—melanoma	8.94e-05	0.000191	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—KRAS—melanoma	8.87e-05	0.00019	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—PPARG—melanoma	8.8e-05	0.000188	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—FGF2—melanoma	8.73e-05	0.000187	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP17A1—melanoma	8.73e-05	0.000187	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP17A1—melanoma	8.72e-05	0.000187	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—VEGFA—melanoma	8.69e-05	0.000186	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—MAPK3—melanoma	8.68e-05	0.000186	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—CTNNB1—melanoma	8.68e-05	0.000186	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	8.61e-05	0.000184	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—VCAN—melanoma	8.6e-05	0.000184	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—NRAS—melanoma	8.59e-05	0.000184	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—AKT1—melanoma	8.56e-05	0.000183	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MMP9—melanoma	8.51e-05	0.000182	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MMP9—melanoma	8.51e-05	0.000182	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—ERBB2—melanoma	8.5e-05	0.000182	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—NOTCH1—melanoma	8.42e-05	0.00018	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—NFKB1—melanoma	8.42e-05	0.00018	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—MAPK1—melanoma	8.26e-05	0.000177	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—EGFR—melanoma	8.26e-05	0.000177	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP17A1—melanoma	8.26e-05	0.000177	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GNA11—melanoma	8.23e-05	0.000176	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MAPK3—melanoma	8.22e-05	0.000176	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MMP2—melanoma	8.08e-05	0.000173	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MAP2K1—melanoma	8.06e-05	0.000173	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—FASN—melanoma	8.06e-05	0.000172	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—ERBB2—melanoma	8.05e-05	0.000172	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—PPARG—melanoma	7.95e-05	0.00017	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—SLC5A5—melanoma	7.93e-05	0.00017	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MAPK1—melanoma	7.82e-05	0.000167	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—EGFR—melanoma	7.82e-05	0.000167	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—KRAS—melanoma	7.8e-05	0.000167	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GNA11—melanoma	7.8e-05	0.000167	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—HRAS—melanoma	7.75e-05	0.000166	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—HRAS—melanoma	7.74e-05	0.000166	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—FGF2—melanoma	7.67e-05	0.000164	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CD44—melanoma	7.65e-05	0.000164	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GNAQ—melanoma	7.65e-05	0.000164	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—VEGFA—melanoma	7.64e-05	0.000164	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—VEGFA—melanoma	7.64e-05	0.000163	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—FASN—melanoma	7.63e-05	0.000163	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—STAT3—melanoma	7.57e-05	0.000162	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—NRAS—melanoma	7.55e-05	0.000162	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—NRAS—melanoma	7.54e-05	0.000161	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—HRAS—melanoma	7.54e-05	0.000161	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—SLC5A5—melanoma	7.51e-05	0.000161	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—HRAS—melanoma	7.48e-05	0.00016	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—CTNNB1—melanoma	7.44e-05	0.000159	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—IL6—melanoma	7.42e-05	0.000159	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—IL6—melanoma	7.41e-05	0.000158	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—KRAS—melanoma	7.39e-05	0.000158	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP1B1—melanoma	7.35e-05	0.000157	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP1B1—melanoma	7.34e-05	0.000157	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MMP9—melanoma	7.29e-05	0.000156	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP17A1—melanoma	7.25e-05	0.000155	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GNAQ—melanoma	7.25e-05	0.000155	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CD44—melanoma	7.25e-05	0.000155	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	7.25e-05	0.000155	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MAPK3—melanoma	7.23e-05	0.000155	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MAPK3—melanoma	7.23e-05	0.000155	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—NFKB1—melanoma	7.22e-05	0.000154	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—IL6—melanoma	7.21e-05	0.000154	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CG—melanoma	7.13e-05	0.000153	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—ERBB2—melanoma	7.08e-05	0.000151	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—CTNNB1—melanoma	7.05e-05	0.000151	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP1B1—melanoma	6.95e-05	0.000149	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MMP9—melanoma	6.91e-05	0.000148	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PPARG—melanoma	6.88e-05	0.000147	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MAPK1—melanoma	6.88e-05	0.000147	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—EGFR—melanoma	6.88e-05	0.000147	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MAPK1—melanoma	6.87e-05	0.000147	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—EGFR—melanoma	6.87e-05	0.000147	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GNA11—melanoma	6.85e-05	0.000147	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—AKT1—melanoma	6.84e-05	0.000146	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—NFKB1—melanoma	6.83e-05	0.000146	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PLCB4—melanoma	6.79e-05	0.000145	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—FASN—melanoma	6.7e-05	0.000143	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—AKT1—melanoma	6.66e-05	0.000142	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—HRAS—melanoma	6.63e-05	0.000142	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—SLC5A5—melanoma	6.59e-05	0.000141	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—VEGFA—melanoma	6.55e-05	0.00014	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TNF—melanoma	6.55e-05	0.00014	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—KRAS—melanoma	6.5e-05	0.000139	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—KRAS—melanoma	6.49e-05	0.000139	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—STAT3—melanoma	6.49e-05	0.000139	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—NRAS—melanoma	6.47e-05	0.000138	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIP4K2A—melanoma	6.38e-05	0.000137	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC6A11—melanoma	6.38e-05	0.000137	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CD44—melanoma	6.37e-05	0.000136	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GNAQ—melanoma	6.37e-05	0.000136	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—IL6—melanoma	6.35e-05	0.000136	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—HRAS—melanoma	6.28e-05	0.000134	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CD—melanoma	6.27e-05	0.000134	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—MTAP—melanoma	6.21e-05	0.000133	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—VEGFA—melanoma	6.2e-05	0.000133	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MAPK3—melanoma	6.2e-05	0.000133	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—CTNNB1—melanoma	6.19e-05	0.000133	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ALB—melanoma	6.19e-05	0.000132	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—STAT3—melanoma	6.14e-05	0.000131	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—NRAS—melanoma	6.13e-05	0.000131	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP1B1—melanoma	6.11e-05	0.000131	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MMP9—melanoma	6.07e-05	0.00013	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ABCB1—melanoma	6.04e-05	0.000129	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—IL6—melanoma	6.01e-05	0.000129	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—NFKB1—melanoma	6.01e-05	0.000129	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MAPK1—melanoma	5.9e-05	0.000126	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—EGFR—melanoma	5.89e-05	0.000126	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MAPK3—melanoma	5.87e-05	0.000126	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ABCB1—melanoma	5.72e-05	0.000122	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TNF—melanoma	5.61e-05	0.00012	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MAPK1—melanoma	5.58e-05	0.00012	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—EGFR—melanoma	5.58e-05	0.000119	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—KRAS—melanoma	5.57e-05	0.000119	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PRKCA—melanoma	5.56e-05	0.000119	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PHGDH—melanoma	5.53e-05	0.000118	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—LUM—melanoma	5.53e-05	0.000118	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—HRAS—melanoma	5.52e-05	0.000118	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—HRAS—melanoma	5.52e-05	0.000118	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ERCC2—melanoma	5.52e-05	0.000118	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CB—melanoma	5.46e-05	0.000117	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—VEGFA—melanoma	5.45e-05	0.000117	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HPSE—melanoma	5.43e-05	0.000116	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTGS2—melanoma	5.41e-05	0.000116	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—STAT3—melanoma	5.4e-05	0.000116	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—NRAS—melanoma	5.38e-05	0.000115	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CUBN—melanoma	5.33e-05	0.000114	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TNF—melanoma	5.32e-05	0.000114	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—IL6—melanoma	5.28e-05	0.000113	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—IL6—melanoma	5.28e-05	0.000113	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—KRAS—melanoma	5.27e-05	0.000113	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PRKCA—melanoma	5.27e-05	0.000113	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ERCC2—melanoma	5.22e-05	0.000112	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MAPK3—melanoma	5.16e-05	0.00011	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SDHD—melanoma	5.15e-05	0.00011	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CSPG4—melanoma	5.15e-05	0.00011	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—BSG—melanoma	5.15e-05	0.00011	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ABCB1—melanoma	5.03e-05	0.000108	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GPAM—melanoma	4.98e-05	0.000107	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MAPK1—melanoma	4.91e-05	0.000105	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EGFR—melanoma	4.9e-05	0.000105	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ACER3—melanoma	4.9e-05	0.000105	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—AKT1—melanoma	4.87e-05	0.000104	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—HRAS—melanoma	4.73e-05	0.000101	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTEN—melanoma	4.72e-05	0.000101	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TNF—melanoma	4.67e-05	0.0001	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MAPK3—melanoma	4.66e-05	9.97e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—KRAS—melanoma	4.63e-05	9.92e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PRKCA—melanoma	4.63e-05	9.9e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ERCC2—melanoma	4.59e-05	9.82e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—IL6—melanoma	4.53e-05	9.7e-05	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MYC—melanoma	4.53e-05	9.7e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—HRAS—melanoma	4.48e-05	9.59e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—UGT2B10—melanoma	4.48e-05	9.59e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CG—melanoma	4.36e-05	9.32e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—IL6—melanoma	4.29e-05	9.18e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PLA2G6—melanoma	4.24e-05	9.07e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PPARG—melanoma	4.2e-05	9e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—AKT1—melanoma	4.18e-05	8.95e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HS3ST5—melanoma	4.17e-05	8.91e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CG—melanoma	4.13e-05	8.83e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PPARG—melanoma	3.98e-05	8.52e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—AKT1—melanoma	3.96e-05	8.47e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—HRAS—melanoma	3.94e-05	8.43e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CD—melanoma	3.83e-05	8.2e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—VCAN—melanoma	3.81e-05	8.15e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ALB—melanoma	3.78e-05	8.09e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—IL6—melanoma	3.77e-05	8.07e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CD—melanoma	3.63e-05	7.76e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CG—melanoma	3.62e-05	7.76e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ALB—melanoma	3.58e-05	7.66e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PPARG—melanoma	3.5e-05	7.49e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—AKT1—melanoma	3.48e-05	7.44e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CB—melanoma	3.34e-05	7.14e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CA—melanoma	3.33e-05	7.13e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTGS2—melanoma	3.31e-05	7.08e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP17A1—melanoma	3.21e-05	6.87e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CD—melanoma	3.19e-05	6.82e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CB—melanoma	3.16e-05	6.77e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PLCB4—melanoma	3.16e-05	6.76e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ALB—melanoma	3.15e-05	6.73e-05	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—AKT1—melanoma	3.14e-05	6.72e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTGS2—melanoma	3.13e-05	6.7e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GNA11—melanoma	3.03e-05	6.49e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC6A11—melanoma	2.97e-05	6.35e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIP4K2A—melanoma	2.97e-05	6.35e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—FASN—melanoma	2.97e-05	6.35e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC5A5—melanoma	2.92e-05	6.25e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MTAP—melanoma	2.89e-05	6.18e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTEN—melanoma	2.88e-05	6.17e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CD44—melanoma	2.82e-05	6.03e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GNAQ—melanoma	2.82e-05	6.03e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CB—melanoma	2.78e-05	5.94e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTGS2—melanoma	2.75e-05	5.89e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTEN—melanoma	2.73e-05	5.85e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—AKT1—melanoma	2.72e-05	5.82e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP1B1—melanoma	2.7e-05	5.79e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PHGDH—melanoma	2.57e-05	5.51e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—LUM—melanoma	2.57e-05	5.51e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HPSE—melanoma	2.52e-05	5.4e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CUBN—melanoma	2.48e-05	5.3e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTEN—melanoma	2.4e-05	5.14e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SDHD—melanoma	2.39e-05	5.12e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—BSG—melanoma	2.39e-05	5.12e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CSPG4—melanoma	2.39e-05	5.12e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GPAM—melanoma	2.32e-05	4.96e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ABCB1—melanoma	2.23e-05	4.76e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PRKCA—melanoma	2.05e-05	4.38e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CA—melanoma	2.03e-05	4.36e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ERCC2—melanoma	2.03e-05	4.35e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PLA2G6—melanoma	1.97e-05	4.22e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CA—melanoma	1.93e-05	4.12e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—VCAN—melanoma	1.77e-05	3.79e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CA—melanoma	1.69e-05	3.62e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AKT1—melanoma	1.66e-05	3.56e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CG—melanoma	1.6e-05	3.43e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AKT1—melanoma	1.57e-05	3.37e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PPARG—melanoma	1.55e-05	3.31e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP17A1—melanoma	1.49e-05	3.2e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CD—melanoma	1.41e-05	3.02e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GNA11—melanoma	1.41e-05	3.02e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALB—melanoma	1.39e-05	2.98e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AKT1—melanoma	1.38e-05	2.96e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—FASN—melanoma	1.38e-05	2.95e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC5A5—melanoma	1.36e-05	2.9e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GNAQ—melanoma	1.31e-05	2.81e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CD44—melanoma	1.31e-05	2.81e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP1B1—melanoma	1.26e-05	2.69e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CB—melanoma	1.23e-05	2.63e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTGS2—melanoma	1.22e-05	2.61e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTEN—melanoma	1.06e-05	2.27e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ABCB1—melanoma	1.03e-05	2.21e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PRKCA—melanoma	9.52e-06	2.04e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ERCC2—melanoma	9.45e-06	2.02e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CA—melanoma	7.49e-06	1.6e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CG—melanoma	7.46e-06	1.6e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PPARG—melanoma	7.2e-06	1.54e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CD—melanoma	6.56e-06	1.4e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALB—melanoma	6.47e-06	1.39e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKT1—melanoma	6.12e-06	1.31e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CB—melanoma	5.72e-06	1.22e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTGS2—melanoma	5.66e-06	1.21e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTEN—melanoma	4.94e-06	1.06e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CA—melanoma	3.48e-06	7.46e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKT1—melanoma	2.85e-06	6.09e-06	CbGpPWpGaD
